Áõ·Ê   Çлý¹ßÇ¥   °øÇØ   ¸é¿ªÄ¡·á   ÇÑÀÇÇп¡ ´ëÇÑ ³ªÀÇ ÀÌÇØ 
 
[¸ÞÀϸµ½Åû/Å»Åð]
  °íÁ¤°Ë»ö :  ¾Ë·¹¸£±â°³·Ð  /  ¾Ë·¹¸£°Õ  /  ±â°üÁöõ½Ä  /  ¾ÆÅäÇÇÇǺο°  /  À½½Ä¾Ë·¹¸£±â  /  µÎµå·¯±â  /  ¾Ë·¹¸£±âºñ¿° [ÃÖ½ÅÀÚ·á]
ÇöÀçÀ§Ä¡ : ¾Ë·¹¸£±â ÃֽŴº½º
 
 Ãâ·Â    ¸ÞÀÏ    ¸®½ºÆ®    Ãßõ
½Ì±Ö·¹¾î¿Í ÀÚ»ì

ÀÔ·ÂÀÏ:2008-04-08 / Á¶È¸¼ö:7765 / Ãßõ¼ö:333 / ÀÛ¼ºÀÚ:ÇѸ¸¿ë

 

½Ì±Ö·¹¾î´Â õ½Ä Ä¡·áÁ¦·Î °¡Àå ¸¹ÀÌ ¾²ÀÌ´Â ¾àÁ¦ÀÌ´Ù. ºñ·Ï ÈíÀÔ¿ë ½ºÅ×·ÎÀÌµå º¸´Ù´Â È¿°ú°¡ ¶³¾îÁöÁö¸¸ ±× Æí¸®¼º°ú Á¢±Ù¼ºÀ¸·Î ÀÎÇؼ­ Áö³­ÇØ ¿ì¸®³ª¶ó¿¡¼­µµ ÈíÀÔ¿ë ½ºÅ×·ÎÀ̵庸´Ù ´õ ¸¹ÀÌ Ãµ½Ä Ä¡·áÁ¦·Î »ç¿ëµÇ¾ú´Ù.

 

ÃÖ±Ù ¹Ì±¹¿¡¼­ ½Ì±Ö·¹¾î¿Í ÀÚ»ì°úÀÇ °ü·Ã¼ºÀ» º¸°íÇÑ ÄÉÀ̽º°¡ ÀÖ¾î ¹Ì±¹ ½Ä¾àû¿¡¼­´Â À̸¦ ¸ÓÅ©»ç¿¡ °ü·ÃÁ¶»ç¸¦ 9°³¿ù ³»¿¡ º¸°íÇϵµ·Ï ¿äûÇÏ¿´´Ù. ÀÌ¿¡´ëÇÑ ´º½º°¡ ¿Ü±¹ ´º½º¸¦ ÅëÇؼ­ ¿ì¸®¿¡°Ôµµ Àü´ÞµÇ°í ÀÖ´Ù.

 

µ¥Àϸ® ÆÊ   2008³â 3¿ù 28ÀÏ

    FDA, õ½Ä¾à '½Ì±Ö·¹¾î' ÀÚ»ì À§Ç輺 Á¶»ç

    ÀÛ³â10¿ùÀÌ·¡ 3~4°Ç º¸°í...9°³¿ù °¡·® ¼Ò¿äµÉµí

    ¹Ì±¹ FDA´Â ¸ÓÅ©ÀÇ ¡®½Ì±Ö·¹¾î(Singulair)¡¯°¡ ÀÚ»ì À¯¹ß°ú ¿¬°üµÅ ÀÖ´ÂÁö Á¶»ç ÁßÀ̶ó°í 27ÀÏ ¹ßÇ¥Çß´Ù.

    FDA °ü°èÀÚ´Â "½Ì±Ö·¹¾î º¹¿ëÀÚÀÇ °¨Á¤º¯È­, ÀÚ»ìÇൿ°ú ÀÚ»ì°ú °ü·ÃµÈ º¸°í¸¦ °ËÅä Áß"À̶ó°í ¸»Çß´Ù.

    ÀÌ¹Ì ¸ÓÅ©»ç´Â Àü°£, ¿ì¿ïÁõ°ú ÀÚ»ìÇൿ µîÀÇ ºÎÀÛ¿ë Ãß°¡·Î ½Ì±Ö·¹¾î ¶óº§À» ³×¹ø ¾÷µ¥ÀÌÆ®ÇÑ ¹Ù ÀÖ´Ù.

    ÃÖ±Ù¿¡ ÀÚ»ìÇൿ°ú Ã浿¿¡ ´ëÇÑ ºÎÀÛ¿ëÀ» Ãß°¡Çϱ⵵ Çß´Ù.

    À̹ø À§Ç輺 Á¶»ç´Â Áö³­ 10¿ù ÀÌÈÄ 3~4°ÇÀÇ ÀÚ»ì º¸°í Á¢¼ö¿¡ ÀÇÇÑ °ÍÀ¸·Î ¾Ë·ÁÁ³´Ù. °ËÅä´Â ´ë·« 9°³¿ù Á¤µµ °É¸± °ÍÀ̶ó°í FDA °ü°èÀÚ´Â Àü¸ÁÇß´Ù.

    FDA´Â ÃÖ±Ùµé¾î ºÎÀÛ¿ë °ü·Ã °ËÅ並 ¸¶Ä¡±â Àü¿¡ ¹Ì¸® ´ëÁß¿¡°Ô °ø°³ Çϴµ¥ ÀÌ´Â ºÎÀÛ¿ë °ø°³¸¦ ´Ê°Ô ÇÑ´Ù´Â ºñ³­À» ¸éÇϱâ À§ÇÑ °ÍÀÌ´Ù.

    ¸ÓÅ© °ü°èÀÚ´Â "À̹ø FDAÀÇ Á¶»ç´Â ÀÓ»ó½ÇÇè¿¡ ´ëÇÑ °ÍÀº ¾Æ´Ï°í FDA¿¡ º¸°íµÈ ÀÚ·á¿¡ ´ëÇÑ °ËÅä"¶ó°í ¸»Çß´Ù. ¶ÇÇÑ "½Ì±Ö·¹¾î¿¡ ´ëÇÑ 1¸¸1000¸íÀ» ´ë»óÀ¸·Î ÇÏ´Â 40°ÇÀÇ ÀÓ»ó½ÇÇè¿¡¼­ ÀÚ»ì°ü·Ã ºÎÀÛ¿ëÀº ¾ø¾ú´Ù"°í µ¡ºÙ¿´´Ù.

    À۳⠽ַ̱¹¾îÀÇ ¿¬¸ÅÃâÀº 43¾ï´Þ·¯. ¾Ë·¯Áö¿Í õ½Ä Ä¡·áÁ¦·Î 1998³â¿¡ FDA·ÎºÎÅÍ ½ÂÀι޾ҴÙ. ½Ì±Ö·¹¾î´Â ¾Æ½ºÆ®¶óÁ¦³×Ä«ÀÇ ¡®¾ÆÄÝ·¹ÀÌÆ®(Accolate)¡¯¿Í Å©¸®Æ¼Ä®»çÀÇ ¡®ÀÚÀÌÇ÷Î(Zyflo)¡¯¿Í °°Àº °è¿­ÀÇ ¾à¹°.

    FDA´Â ½Ì±Ö·¹¾î»Ó¸¸ ¾Æ´Ï¶ó ¾ÆÄÝ·¹ÀÌÆ®¿Í ÀÚÀÌÇ÷ο¡ ´ëÇÑ ÀÚ·á °ËÅäµµ º´ÇàÇÒ °ÍÀ̶ó°í ¹àÇû´Ù.

 

ÀÌ·¯ÇÑ Á¶»ç¸¦ ¿ä±¸ÇÑ °ÍÀº º¸Åë ¾à¹°À» ½ÃÆÇ ÇÑ ÈÄ ºÎÀÛ¿ëÀ» ¸ð´ÏÅ͸µÇÏ°Ô µÇ´Âµ¥ À̶§ ½Ì±Ö·¹¾î ¸Ô´ø ¾ÆÀ̵éÀÌ ÀÚ»ìÇÑ º¸°í°¡ ¸î °Ç º¸°íµÇ¾ú±â ¶§¹®ÀÌ´Ù.

 

±×·¸´Ù¸é ½Ì±Ö·¹¾î¿Í ÀÚ»ìÀº ¿¬°ü¼ºÀÌ ÀÖÀ»±î ?

 

Áö±ÝÀ¸·Î¼± ÀÌ¿¡´ëÇÑ °ü·ÃµÈ ¿¬±¸°¡ ¾øÀ¸¹Ç·Î ¸ð¸£°Ú´Ù°í ¸»ÇÏ´Â °ÍÀÌ ÁÁÀ» µíÇÏ´Ù. ÀÚ»ì °ÆÁ¤À¸·Î ½Ì±Ö·¹¾î ¸Ô´Â °ÍÀ» ²÷´Â °ÍÀº ±×¸® Çö¸íÇÑ ¹æ¹ýÀº ¾Æ´Ò µí ÇÏ´Ù.

 

ÀÌ·¯ÇÑ º¸°í¿¡ ´ëÇؼ­ ¹Ì±¹ ¾Ë·¹¸£±â ÇÐȸ´Â ´ÙÀ½°ú °°Àº ±Ç°í»çÇ×À» ¹ßÇ¥ÇÏ¿´´Ù.

 

AAAAI º¸°í»çÇ×

    Leadership from the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma & Immunology released the following statement in response to the Thursday announcement of a Food and Drug Administration investigation into Singulair:

    There are no data from well-designed studies to indicate a link between Singulair and suicide. The concern expressed by the FDA is based entirely on case reports and there is no indication that such effects apply to other leukotriene-modifying medications.

    Post-marketing case reports are incomplete. Furthermore, comparative data are lacking on the incidence of suicide in the general population versus the incidence in patients taking Singulair. Thus, it is unknown whether there is an increased incidence of suicide in patients receiving Singulair.

    Based on the information currently available, patients taking Singulair should continue to take the medication as prescribed provided: 1) the patient and physician feel the medication is effective; and 2) the patient does not experience any suicidal behavior or thoughts.

    Patients who experience suicidal thoughts or demonstrate suicidal behavior should consult their physician immediately to discuss whether to continue with this medication. Patients should not hesitate to consult their physician if they feel uncomfortable continuing on the medication.

    American Academy of Allergy Asthma & Immunology

     

 

 

 
100ÀÚÆò ¾²±â  À̸§: ÀÔ·ÂÀÏ:2024-03-29 
 
ÀÛ¼ºÀÚ : washington dc
KM1OhE Major thankies for the article. Really Cool.
ÀÛ¼ºÀÚ : washington dc
bCW5Jm Simply wanna remark that you have a very nice internet site , I enjoy the design and style it really stands out.
ÀÛ¼ºÀÚ : Zoe
Great post with lots of ipmrotnat stuff.
ÀÛ¼ºÀÚ : suzanelyk
It agree, the remarkable message
ÀÛ¼ºÀÚ : Zoothhoks
I confirm. I join told all above.
 
 
°íÁ¤°Ë»ö :  ¾Ë·¹¸£±â°³·Ð  /  ¾Ë·¹¸£°Õ  /  ±â°üÁöõ½Ä  /  ¾ÆÅäÇÇÇǺο°  /  À½½Ä¾Ë·¹¸£±â  /  µÎµå·¯±â  /  ¾Ë·¹¸£±âºñ¿°  
Á¤º¸Á¦°ø¿øÄ¢¤ÓÁ¤º¸°øÀ¯¹æ¿î¿µ¿øÄ¢¤ÓÀúÀ۱ǰü·Ã¤Ó°³ÀÎÁ¤º¸º¸È£¿øÄ¢¤ÓÀ̸ÞÀϹ«´Ü¼öÁý°ÅºÎ¤Ó°íÁ¤ÇÊÁø±¸ÇÔ¤ÓºñÁ¯°ú »ç¸í
¸ðµç ±ÛÀº ÀúÀÛ±Ç ¹ýÀÇ º¸È£¸¦ ¹Þ´Â ¹Ù ¹«´Ü ÀüÀç. º¹»ç. ¹èÆ÷µîÀ» ±ÝÇÕ´Ï´Ù.